Compare CMTL & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMTL | ICCC |
|---|---|---|
| Founded | 1967 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.4M | 55.5M |
| IPO Year | N/A | 1987 |
| Metric | CMTL | ICCC |
|---|---|---|
| Price | $3.50 | $5.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 195.9K | 18.8K |
| Earning Date | 01-12-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $499,528,000.00 | $27,769,304.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.15 | N/A |
| P/E Ratio | ★ N/A | $21.23 |
| Revenue Growth | N/A | ★ 16.49 |
| 52 Week Low | $1.19 | $4.28 |
| 52 Week High | $4.88 | $7.60 |
| Indicator | CMTL | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 67.64 | 53.46 |
| Support Level | $3.17 | $4.72 |
| Resistance Level | $3.32 | $5.36 |
| Average True Range (ATR) | 0.21 | 0.31 |
| MACD | 0.04 | 0.12 |
| Stochastic Oscillator | 96.81 | 77.73 |
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.